Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (171-180 of 306) with videos related to

Pageof 31
Sort By:
Oncology|November 17, 2021
Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis StageNorio Akuta, Yusuke Kawamura, Fumitaka Suzuki, et al.
Journal of Gastroenterology|November 27, 2004
Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001Mariko Kobayashi, Fumitaka Suzuki, Yasuji Arase, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2018
A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body MyositisToru Kuwano, Norio Akuta, Fumitaka Suzuki, et al.
Journal of Medical Virology|July 2, 2017
Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virusMitsutaka Osawa, Norio Akuta, Fumitaka Suzuki, et al.
Journal of Gastroenterology|March 23, 2012
Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virusMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Medical Virology|November 22, 2005
Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and CMariko Kobayashi, Norio Akuta, Fumitaka Suzuki, et al.
Journal of Medical Virology|February 11, 2018
Amino acid substitutions in the hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by all-oral direct-acting antiviral regimensFumihiro Ogata, Norio Akuta, Masahiro Kobayashi, et al.
Intervirology|September 5, 2009
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 2a high viral load and virological response to interferon-ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Internal Medicine (Tokyo, Japan)|March 3, 2009
Combination therapy of peginterferon and ribavirin for chronic hepatitis C patients with genotype 1b and low-virus loadYasuji Arase, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Medical Virology|January 20, 2009
A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological responseNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Pageof 31

Showing results (171-180 of 306) with videos related to

Sort By:
Pageof 31
Oncology|November 17, 2021
Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis StageNorio Akuta, Yusuke Kawamura, Fumitaka Suzuki, et al.
Journal of Gastroenterology|November 27, 2004
Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001Mariko Kobayashi, Fumitaka Suzuki, Yasuji Arase, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2018
A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body MyositisToru Kuwano, Norio Akuta, Fumitaka Suzuki, et al.
Journal of Medical Virology|July 2, 2017
Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virusMitsutaka Osawa, Norio Akuta, Fumitaka Suzuki, et al.
Journal of Gastroenterology|March 23, 2012
Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virusMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Medical Virology|November 22, 2005
Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and CMariko Kobayashi, Norio Akuta, Fumitaka Suzuki, et al.
Journal of Medical Virology|February 11, 2018
Amino acid substitutions in the hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by all-oral direct-acting antiviral regimensFumihiro Ogata, Norio Akuta, Masahiro Kobayashi, et al.
Intervirology|September 5, 2009
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 2a high viral load and virological response to interferon-ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Internal Medicine (Tokyo, Japan)|March 3, 2009
Combination therapy of peginterferon and ribavirin for chronic hepatitis C patients with genotype 1b and low-virus loadYasuji Arase, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Medical Virology|January 20, 2009
A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological responseNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Pageof 31